We are part of this outstanding Academy of Kidney Cancer Investigators David Braun Abhishek Chakraborty Ritesh Kotecha Amrita Mangalvedhekar and Krishnendu Pal. Thank you for your leadership and guidance Brian Rini, MD

New work on SDH-/FH-deficient RCC from our Memorial Sloan Kettering Cancer Center Kidney Cancer Team, driven by (newly matched!) med student Angela Yoo, Cerise Tang, and Mark Zucker. Thanks ari hakimi Ritesh Kotecha, all collaborators, and of course the patients who contributed sciencedirect.com/science/articl…

Last #KCRS22 tweet: Ritesh Kotecha and I went to Midland Public Schools ‘s Dow High years ago. Now, as a GU #geneticcounselor and #oncologist , conference run ins have become a norm. Mr. Koski (our AP Bio teacher) would be so proud. #michiganstrong

Genetic ancestry and molecular correlations in patients with #KidneyCancer. Presentation by Ritesh Kotecha Memorial Sloan Kettering Cancer Center. #IKCSNA22 written coverage by Mike Lattanzi Texas Oncology > bit.ly/3h3y53l Kidney Cancer

Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations buff.ly/3Uf2NoX Chung-Han Lee 李宗翰, MD/PhD Ritesh Kotecha David H Aggen, MD PhD Neil Shah Dr. Darren Feldman Robert Motzer MD

(1/n) Our latest work in Eur Urol Focus bit.ly/3YxpWnL is a retrospective study from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center reporting outcomes with ICT by CN status in patients with sarcomatoid and/or rhabdoid dediff Pavlos Msaouel ari hakimi Ritesh Kotecha

Thank you Kidney Cancer for this tremendous & humbling opportunity to help advance the field of research for patients affected by kidney cancer! Incredibly grateful for support of my mentors & collaborators at Wilmot Cancer Institute & Memorial Sloan Kettering Cancer Center that made the proposal possible

📣Dr. Rupesh Kotecha, chief of radiosurgery, has been invited to present with the Middle Eastern Society for Stereotactic and Functional Neurosurgery at their first-ever Stereotactic Radiosurgery Webinar. @RrKotecha will be discussing the current state of modern #SRS platforms.

A new article from our group with Ritesh Kotecha and led by Lennert Eismann + Amy Xie reports that investigational RNA biomarkers in RCC (and likely other diseases) are sensitive to tissue source site (i.e. whether they are obtained from primary or met tissue) sciencedirect.com/science/articl…

Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors buff.ly/3UON4PS

New research from Memorial Sloan Kettering Cancer Center takes a step toward off-the-shelf CAR T cell therapy for #cancer. Author Karlo Perica explains his and Michel Sadelain's recent study in nature that demonstrated cells from healthy donors can be stored for future use. bit.ly/40W306e

Our paper on IO combinations in metastatic translocation RCC is now online. Great collaborative work and addition to treatment outcomes in this rare entity. journals.lww.com/immunotherapy-… nirm Sumanta K. Pal, MD, FASCO Ritesh Kotecha Matthew Zibelman

🔍 2pm at #KCRS25: Trials in Progress led by Robert Motzer MD - packed w updates you won’t want to miss: Nazli Dizman IVORY Ritesh Kotecha ENPP3 x CD3 Bradley McGregor STRIKE Praful Ravi LASER Karie Runcie, MD EXACT Wenxin (Vincent) Xu NK cell immune therapy Plenty to discuss!